Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials

被引:0
作者
He, Xing-Xing [1 ]
Ye, Da-Wei [2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Liver & Gastrointestinal Dis, Tongji Med Coll, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; epigenetic alteration; targeted therapy; diagnosis; prognosis; bioinformatic analysis;
D O I
10.3389/fonc.2022.905654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 1 条
  • [1] Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
    Luo, Xiang-Yuan
    Wu, Kong-Ming
    He, Xing-Xing
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)